Abstract:Nanoparticles (NPs) that are ∼100 nm in diameter can potentially cause toxicity in the central nervous system (CNS). Although NPs exhibit positive aspects, these molecules primarily exert negative or harmful effects. Thus, the beneficial and harmful effects should be compared. The prevalence of neurodegenerative diseases, such as Alzheimer disease, Parkinson disease, and some brain tumors, has increased. However, the major cause of these diseases remains unknown. NPs have been considered as one of the major potential causes of these diseases, penetrating the human body via different pathways. This review summarizes various pathways for NP-induced neurotoxicity, suggesting the development of strategies for nanoneuroprotection using in silico and biological methods. Studies of oxidative stress associated with gene expression analyses provide efficient information for understanding neuroinflammation and neurodegeneration associated with NPs. The brain is a sensitive and fragile organ, and evolution has developed mechanisms to protect it from injury; however, this protection also hinders the methods used for therapeutic purposes. Thus, brain and CNS-related diseases that are the cause of disability and disorder are the most difficult to treat. There are many obstacles to drug delivery in the CNS, such as the blood brain barrier and blood tumor barrier. Considering these barriers, we have reviewed the strategies available to map NPs using biological techniques. The surface adsorption energy of NPs is the basic force driving NP gathering, protein corona formation, and many other interactions of NPs within biological systems. These interactions can be described using an approach named the biological surface adsorption index. A quantitative structural activity relationship study helps to understand different protein-protein or protein-ligand interactions. Moreover, equilibrium between cerebrovascular permeability is required when a drug is transferred via the circulatory system for the therapy of neurodegenerative diseases. Various drug delivery approaches, such as chemical drug delivery and carrier-mediated drug delivery, have been established to avoid different barriers inhibiting CNS penetration by therapeutic substances. Developing an improved understanding of drug receptors and the sites of drug action, together with advances in medicinal chemistry, will make it possible to design drugs with greatly enhanced activity and selectivity; this may result in a significant increase in the therapeutic index.

Brain Localization and Neurotoxicity Evaluation of Polysorbate 80-Modified Chitosan Nanoparticles in Rats.

Specific Role of Polysorbate 80 Coating on the Targeting of Nanoparticles to the Brain

The Joint Effects of Nanoplastics and TBBPA on Neurodevelopmental Toxicity Incaenorhabditis Elegans

Brain Targeting Property and Cytotoxicity Evaluation of H102 Loaded PEG-PLGA Nanoparticles Coated with Polysorbate 80

Implications for blood-brain-barrier permeability, in vitro oxidative stress and neurotoxicity potential induced by mesoporous silica nanoparticles: effects of surface modification

Chitosan Nanoparticles and Their Tween 80 Modified Counterparts Disrupt the Developmental Profile of Zebrafish Embryos.

Bioeffects of Inhaled Nanoplastics on Neurons and Alteration of Animal Behaviors through Deposition in the Brain

Protective effect of surface-modified berberine nanoparticles against LPS-induced neurodegenerative changes: a preclinical study

Rutile TiO2 Particles Exert Size and Surface Coating Dependent Retention and Lesions on the Murine Brain

A review on potential neurotoxicity of titanium dioxide nanoparticles

Neurotoxicity of Silica Nanoparticles: Brain Localization and Dopaminergic Neurons Damage Pathways

Exposure to different surface-modified polystyrene nanoparticles caused anxiety, depression, and social deficit in mice via damaging mitochondria in neurons

The Effect of Lipid Nanoparticle Pegylation on Neuroinflammatory Response in Mouse Brain

Cellular Absorption of Polystyrene Nanoplastics with Different Surface Functionalization and the Toxicity to RAW264.7 Macrophage Cells

Potential neurotoxicity of nanoparticles.

Experimental Studies on the Intracranial Biocompatibility of Chitosan

Nanoneurotoxicity to Nanoneuroprotection Using Biological and Computational Approaches

In-vivo time course of organ uptake and blood-brain-barrier permeation of poly(L-lactide) and poly(perfluorodecyl acrylate) nanoparticles with different surface properties in unharmed and brain-traumatized rats

Time-dependent Translocation and Potential Impairment on Central Nervous System by Intranasally Instilled TiO2 Nanoparticles

Neurotoxicity, behavioral changes and gene-expression profile of mice exposed to SnS2 nanoflowers

Polystyrene nanoplastics induced learning and memory impairments in mice by damaging the glymphatic system